Electrochemical determination of atorvastatin on nano-scaled polypyrrole film

Bioelectrochemistry

Volumn 98, Issue , 2014, Pages 1-10

  Kamalzadeh, Zahra ^a   Shahrokhian, Saeed ^a  

^a SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Atorvastatin; Carbon nanomaterials; Carbon nanoparticles; Carbon nanotubes; Polypyrrole

Indexed keywords

ATORVASTATIN; CARBON; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NANOPARTICLE; POLYMER; POLYPYRROLE; PYRROLE DERIVATIVE;

CHEMICAL STRUCTURE; CHEMISTRY; ELECTROCHEMICAL ANALYSIS; ELECTRODE; LIMIT OF DETECTION; REPRODUCIBILITY; SCANNING ELECTROCHEMICAL MICROSCOPY; SURFACE PROPERTY;

CARBON; ELECTROCHEMICAL TECHNIQUES; ELECTRODES; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIMIT OF DETECTION; MICROSCOPY, ELECTROCHEMICAL, SCANNING; MOLECULAR STRUCTURE; NANOPARTICLES; POLYMERS; PYRROLES; REPRODUCIBILITY OF RESULTS; SURFACE PROPERTIES;

EID: 84894049060     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2014.01.007     Document Type: Article

References (33)

1. Fam D.W.H., Palaniappan Al., Tok A.I.Y., Liedberg B., Moochhala S.M. A review on technological aspects influencing commercialization of carbon nanotube sensors. Sensors Actuators B 2011, 157:1-7.
2. Wang J. Nanomaterial-based electrochemical biosensors. Analyst 2005, 130:421-426.
3. Vashist S.K., Zheng D., Al-Rubeaan K., Luong J.H.T., Sheu F.-S. Advances in carbon nanotube based electrochemical sensors for bioanalytical applications. Biotechnol. Adv. 2011, 29:169-188.
4. Shahrokhian S., Khafaji M. Application of pyrolytic graphite modified with nano-diamond/graphite film for simultaneous voltammetric determination of epinephrine and uric acid in the presence of ascorbic acid. Electrochim. Acta 2010, 55:9090-9096.
5. Raty J.Y., Galli G. First principle study of nanodiamond optical and electronic properties. Comput. Phys. Commun. 2005, 169:14-19.
6. Holt K.B., Caruana D.J., Millán-Barrios E.J. Electrochemistry of undoped diamond nanoparticles: accessing surface redox states. J. Am. Chem. Soc. 2009, 131:11272-11273.
7. Chen L.H., Zang J.B., Wang Y.H., Bian L.Y. Electrochemical oxidation of nitrite on nanodiamond powder electrode. Electrochim. Acta 2008, 53:3442-3445.
8. Gibson N., Shenderova O., Luo T.J.M., Moseenkov S., Bondar V., Puzyr A., Purtov K., Fitzgerald Z., Brenner D.W. Colloidal stability of modified nanodiamond particles. Diamond Relat. Mater. 2009, 18:620-626.
9. Welch C.W., Compton R.G. The use of nanoparticles in electroanalysis: a review. Anal. Bioanal. Chem. 2006, 384:601-619.
10. Banks C.E., Compton R.G. Edge plane pyrolytic graphite electrodes in electroanalysis: an overview. Anal. Sci. 2005, 21:1263-1268.
11. Ates M. A review study of (bio)sensor systems based on conducting polymers. Mater. Sci. Eng. C 2013, 33:1853-1859.
12. Li X., Wang Y., Yang X., Chen J., Fu H., Cheng T. Conducting polymers in environmental analysis, TrAC. Trends Anal. Chem. 2012, 39:163-179.
13. Saumya V., Prathish K.P., Rao T.P. In situ copper oxide modified molecularly imprinted polypyrrole film based voltammetric sensor for selective recognition of tyrosine. Talanta 2011, 85:1056-1062.
14. Kan X., Zhou H., Li C., Zhu A., Xing Z., Zhao Z. Imprinted electrochemical sensor for dopamine recognition and determination based on a carbon nanotube/polypyrrole film. Electrochim. Acta 2012, 63:69-75.
15. Hatchett D.W., Josowicz M. Composites of intrinsically conducting polymers as sensing nanomaterials. Chem. Rev. 2008, 108:746-769.
16. Chakraborty G., Gupta K., Meikap A.K., Babu R., Blau W.J. Synthesis, electrical and magnetotransport properties of polypyrrole-MWCNT nanocomposite. Solid State Commun. 2012, 152:13-18.
17. Shahrokhian S., Kamalzadeh Z., Hamzehloei A. Electrochemical determination of clozapine on MWCNTs/new coccine doped PPY modified GCE: an experimental design approach. Bioelectrochemistry 2013, 90:36-43.
18. Abbar J.C., Nandibewoor S.T. Voltammetric oxidation and determination of atorvastatin based on the enhancement effect of cetyltrimethyl ammonium bromide at a carbon paste electrode. Colloids Surf. B 2013, 106:158-164.
19. Bakker-Arkema R.G., Best J., Fayyad R., Heinonen T.M., Marais A.D., Nawrocki J.M., Black D.M. A brief review paper of the efficacy and safety of atorvastatin in early clinical trials. Atherosclerosis 1997, 131:17-23.
20. Nissen S.E., Nicholls S.J., Sipahi I., Libby P., Raichlen J.S., Ballantyne C.M., Davignon J., Erbel R. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006, 295:1556-1565.
21. Nawrocki J.W., Weiss S.R., Davidson M.H., Sprecher D.L., Schwartz S.L., Lupien P.J., Jones P.H., Haber H.E., Black D.M. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler. Thromb. Vasc. Biol. 1995, 15:678-682.
22. Bakker-Arkema R.G., Davidson M.H., Goldstein R.J., Davignon J., Isaacsohn J.L., Weiss S.R., Keilson L.M., Brown W.V. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA 1996, 275:128-133.
23. Ozaki K., Kubo T., Imaki R., Shinagawa H., Fukaya H., Ohtaki K., Ozaki S., Izumi T. The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia. J. Atheroscler. Thromb. 2006, 13:216-219.
24. Al-Akkam E.J., Abdul Rasool A.A., Badwan A.A., Al-Jbour N.D., Qinna N.A. Development and validation of a sensitive and accurate method for determination of atorvastatin and rosuvastatin in rat plasma by reversed-phase high performance liquid chromatography with UV detection. Int. J. Pharm. Pharm. Sci. 2013, 5:211-219.
25. Dangre S.C., Shah S.K., Suruse P.B., Bhusari K.P. Development of RP-HPLC method for simultaneous estimation of atorvastatin calcium and clopidogrel bisulphate in a pharmaceutical capsule dosage form. Res. J. Pharm. Technol. 2012, 5:641-644.
26. Rukthong P., Sangvanich P., Kitchaiya S., Jantratid E., Sathirakul K. The quantitation of atorvastatin in human plasma by solid phase micro-extraction followed by LC-MS/MS and its application to pharmacokinetics study. Songklanakarin J. Sci. Technol. 2013, 35:41-50.
27. Kotagiri H., Gannu R., Palem C.R., Yamsani S.K., Yamsani V.V., Yamsani M.R. Simultaneous determination of glimepiride and atorvastatin in human serum by high-performance liquid chromatography: application to pharmacokinetic study. J. Liq. Chromatogr. Relat. Technol. 2011, 34:2420-2432.
28. Baghdady Y.Z., Al-Ghobashy M.A., Abdel-Aleem A.A.E., Weshahy S.A. Spectrophotometric and TLC-densitometric methods for the simultaneous determination of Ezetimibe and Atorvastatin calcium. J. Adv. Res. 2013, 4:51-59.
29. Bernard S., Mathew M. Spectrophotometric method of estimation of atorvastatin calcium using sulfo-phospho-vanillin reaction. J. Appl. Pharm. Sci. 2012, 2:150-154.
30. Eskikoy D., Durmus Z., Kilic E. Electrochemical oxidation of atorvastatin and its adsorptive stripping determination in pharmaceutical dosage forms and biological fluids. Collect. Czechoslov. Chem. Commun. 2011, 76:1633-1649.
31. Erk N. Development of electrochemical methods for determination of atorvastatin and analytical application to pharmaceutical products and spiked human plasma. Crit. Rev. Anal. Chem. 2004, 34:1-7.
32. Dogan-Topal B., Uslu B., Ozkan S.A. Investigation of electrochemical behavior of lipid lowering agent atorvastatin calcium in aqueous media and its determination from pharmaceutical dosage forms and biological fluids using boron-doped diamond and glassy carbon electrodes. Comb. Chem. High Throughput Screen. 2007, 10:571-582.
33. Li X., Imin P., Adronov A., Zhitomirsky I. Effect of 5-sulfosalicylic acid and poly [2,5-bis (3-sulfonatopropoxy)-1,4-ethynylphenylene-alt-1,4-ethynylphenylene] on electrodeposition of polypyrrole-carbon nanotube films on stainless steel. Mater. Lett. 2012, 68:24-27.